Apurba Sundar Purkayastha
About Apurba Sundar Purkayastha
Data last updated:
Apurba Sundar Purkayastha is a Director at Cenric Pharmaceuticals Private Limited (since 2019) and Director at Cenric Healthcare Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Cenric Pharmaceuticals Private Limited at ₹4 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cenric Pharmaceuticals Private Limited U24304AS2019PTC019245 | Director | 23 May 2019 | 2019 | ₹4 Lakh (FY 2023) | Active |
 Cenric Healthcare Private Limited U46497AS2025PTC027965 | Director | 08 Apr 2025 | 2025 | Active |
Board colleagues of Apurba Sundar Purkayastha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhishek Purkayastha | 08461125 | Cenric Pharmaceuticals Private Limited , Cenric Healthcare Private Limited | Director |
| Aman Jain | 09580852 | Cenric Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Apurba Sundar Purkayastha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apurba Sundar Purkayastha
Apurba Sundar Purkayastha currently holds 2 directorships: Cenric Pharmaceuticals Private Limited (Director, since 23 May 2019, revenue ₹4 Lakh (FY 2023)); Cenric Healthcare Private Limited (Director, since 08 Apr 2025).
Apurba Sundar Purkayastha was first appointed on 23 May 2019 as Director at Cenric Pharmaceuticals Private Limited. The most recent appointment on record is 08 Apr 2025 at Cenric Healthcare Private Limited.
The current boards of Apurba Sundar Purkayastha's companies include Abhishek Purkayastha (Cenric Pharmaceuticals Private Limited), Aman Jain (Cenric Pharmaceuticals Private Limited).